Levy Harvey L
Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Int J Neonatal Screen. 2021 Jan 19;7(1):5. doi: 10.3390/ijns7010005.
Routine newborn screening for many disorders is now so ingrained in newborn care that there is no question about whether it should be done. However, acceptance of newborn screening was not guaranteed when Robert Guthrie introduced it for phenylketonuria (PKU). This article describes the professional and personal story of Guthrie, a physician and microbiologist, who veered from cancer research to a commitment to prevent intellectual disability from PKU. It recounts how Guthrie was able to overcome strong opposition to mandatory screening from prominent physicians and medical societies, so that newborn screening for PKU would be routinely performed throughout the developed world, and would eventually form the basis for the (much more) comprehensive screening conducted today.
如今,对多种疾病进行新生儿常规筛查在新生儿护理中已根深蒂固,以至于对于是否应该进行筛查已不存在疑问。然而,当罗伯特·古思里将新生儿筛查用于苯丙酮尿症(PKU)时,其被接受并非是必然的。本文讲述了身为医生和微生物学家的古思里的职业和个人故事,他从癌症研究转向致力于预防苯丙酮尿症导致的智力残疾。文章叙述了古思里如何克服来自知名医生和医学协会对强制筛查的强烈反对,从而使苯丙酮尿症的新生儿筛查在整个发达国家得以常规开展,并最终为如今(更为)全面的筛查奠定了基础。